Evidence map›Paper›PMID 39621295›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025

Effect of Resveratrol on the intestinal microbiota in Type2 diabetes Mellitus mice.

Hao Liu, Shumin Wang, Xin Yu, Shuguang Sun, Yingzhen Su

Abstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hao Liu *Medical College, Kunming University, Kunming, 650214, Yunnan, P.R. China.ORCID http://orcid.org/0009-0009-0691-0164
Shumin Wang *Medical College, Kunming University, Kunming, 650214, Yunnan, P.R. China.
Xin YuSchool of Basic Medicine, School of Clinical Medicine, Dali University, Dali, 671000, China.ORCID http://orcid.org/0000-0002-4860-9355
Shuguang SunDepartment of Endocrinology, School of Clinical Medicine, Dali University, Dali, 671000, China. sshuglily@163.com.ORCID http://orcid.org/0000-0002-0272-8340
Yingzhen SuMedical College, Kunming University, Kunming, 650214, Yunnan, P.R. China. suyingzhen@163.com.ORCID http://orcid.org/0009-0000-2429-5606

Funding

the basic research foundation of Science and Technology Department of Yunnan Province 202101BA070001-112the basic research foundation of Science and Technology Department of Yunnan Province 202201AT070008the National Natural Science Foundation of China funded project 82060149
6 · The paper itself

Abstract

Some natural products have been found to have a positive effect on the treatment of Type 2 Diabetes Mellitus (T2DM). The effective mechanism by which these natural products work may be attributed to their ability to alter the gut microbiome. In this study, considering the beneficial properties of resveratrol for T2DM, the mechanism of resveratrol in releasing of T2DM, the correlation between the apparent traits of resveratrol in T2DM mice and the changes in intestinal flora structure were explored. The intervention of resveratrol in different dose did effectively improve the apparent T2DM symptoms in mice, including reduced fasting blood glucose, enhance to both the insulin tolerance and glucose tolerance. Simultaneously, resveratrol can effectively ameliorate the pathological condition of the colon and rectum in T2DM mice, leading to a reduction in intestinal villi swelling and fat vacuoles. The intervention of resveratrol led to changes in the gut flora structure of T2DM mice. Erysipelas and Ileibacterium are crucial taxa of resveratrol involved in maintaining the balance of the gut microbiota. The abundance of Erysipelotrichaceae and Ileibacterium was significantly elevated under the treatment of resveratrol, and the compose of the gut microbiota was more inclined to healthy mice. T2DM symptoms could be alleviated by resveratrol through different mechanisms compared to metformin intervention.

Indexed as

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeHypoglycemic AgentsResveratrolAnimalsBacteriaBlood GlucoseDisease Models, AnimalHumansMaleMiceMice, Inbred C57BLBlood GlucoseHypoglycemic AgentsResveratrolErysipelotrichaceaeGut microbiotaIleibacteriumResveratrolT2DM

Identifiers

PMID39621295
PMCPMC11885759

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.